Pacira BioSciences, Inc. Net Asset Quality Index
Pacira BioSciences, Inc. net asset quality index. Pacira BioSciences, Inc. (PCRX) has a Net Asset Quality Index of 54.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.24 Billion minus total liabilities of $572.01 Million yields net assets of $671.97 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Pacira BioSciences, Inc. to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Pacira BioSciences, Inc. (2008–2025)
Net asset quality index of Pacira BioSciences, Inc. from 2008 to 2025. This chart shows how Pacira BioSciences, Inc.'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the index stands at 54.0%, representing net assets of $671.97 Million against total assets of $1.24 Billion USD. See PCRX total equity for net asset value and shareholders' equity analysis.
Pacira BioSciences, Inc. Net Asset Quality Index by Year (2008–2025)
Pacira BioSciences, Inc. net asset quality index by year from 2008 to 2025. The table below presents the year-by-year Net Asset Quality Index for Pacira BioSciences, Inc. from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Pacira BioSciences, Inc. (PCRX) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 54.8% | $693.11 Million | $1.26 Billion | $571.81 Million | ▲ +4.7 pp |
| 2024 | 50.1% | $778.35 Million | $1.55 Billion | $775.17 Million | ▼ -5.2 pp |
| 2023 | 55.3% | $870.13 Million | $1.57 Billion | $704.26 Million | ▲ +9.2 pp |
| 2022 | 46.1% | $775.01 Million | $1.68 Billion | $906.19 Million | ▲ +10.9 pp |
| 2021 | 35.2% | $730.41 Million | $2.08 Billion | $1.34 Billion | ▼ -13.4 pp |
| 2020 | 48.6% | $619.69 Million | $1.27 Billion | $654.83 Million | ▲ +5.9 pp |
| 2019 | 42.7% | $354.94 Million | $831.07 Million | $476.12 Million | ▼ -3.9 pp |
| 2018 | 46.6% | $321.23 Million | $689.35 Million | $368.13 Million | ▲ +2.1 pp |
| 2017 | 44.5% | $279.48 Million | $628.37 Million | $348.89 Million | ▼ -11.5 pp |
| 2016 | 55.9% | $218.98 Million | $391.47 Million | $172.49 Million | ▼ -0.1 pp |
| 2015 | 56.1% | $218.39 Million | $389.62 Million | $171.23 Million | ▲ +3.6 pp |
| 2014 | 52.5% | $171.15 Million | $326.07 Million | $154.93 Million | ▲ +28.2 pp |
| 2013 | 24.3% | $41.25 Million | $169.82 Million | $128.57 Million | ▼ -34.5 pp |
| 2012 | 58.8% | $65.86 Million | $112.05 Million | $46.20 Million | ▲ +16.2 pp |
| 2011 | 42.5% | $48.27 Million | $113.49 Million | $65.22 Million | ▲ +115.2 pp |
| 2010 | -72.7% | $-48.38 Million | $66.56 Million | $114.94 Million | ▼ -20.5 pp |
| 2009 | -52.2% | $-22.95 Million | $43.95 Million | $66.90 Million | ▼ -67.0 pp |
| 2008 | 14.8% | $7.49 Million | $50.54 Million | $43.05 Million | — |